JO
TRIB

John Overdeck’s Trinity Biotech TRIB Stock Holding History

John Overdeck’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-622
Closed -$14.8K – 4930
2025
Q4 		$14.8K Sell
622
-178
-22% -$5.25K ﹤0.01% 4014
2025
Q3 		$24.9K Buy
800
+298
+59% +$9.39K ﹤0.01% 3585
2025
Q2 		$9.8K Hold
502
– – ﹤0.01% 3139
2025
Q1 		$8.59K Buy
+502
New +$11.9K ﹤0.01% 3136
2021
Q3 		– Sell
-74
Closed -$33K – 4715
2021
Q2 		$33K Sell
74
-188
-72% -$93.8K ﹤0.01% 3954
2021
Q1 		$148K Sell
262
-593
-69% -$428K ﹤0.01% 3673
2020
Q4 		$489K Buy
+855
New +$424K ﹤0.01% 2536
2019
Q3 		– Sell
-68
Closed -$17K – 3797
2019
Q2 		$17K Hold
68
– – ﹤0.01% 3261
2019
Q1 		$29K Sell
68
-60
-47% -$24.7K ﹤0.01% 2954
2018
Q4 		$44K Sell
128
-34
-21% -$15.7K ﹤0.01% 2870
2018
Q3 		$97K Sell
162
-95
-37% -$61.9K ﹤0.01% 3078
2018
Q2 		$193K Sell
257
-74
-22% -$53.4K ﹤0.01% 3135
2018
Q1 		$256K Sell
331
-156
-32% -$128K ﹤0.01% 2857
2017
Q4 		$373K Sell
487
-111
-19% -$85.9K ﹤0.01% 2622
2017
Q3 		$504K Sell
598
-200
-25% -$167K ﹤0.01% 2145
2017
Q2 		$718K Sell
798
-325
-29% -$276K ﹤0.01% 2099
2017
Q1 		$1M Sell
1,123
-114
-9% -$107K ﹤0.01% 1923
2016
Q4 		$1.28M Buy
1,237
+718
+138% +$742K ﹤0.01% 1838
2016
Q3 		$1.03M Sell
519
-81
-14% -$151K ﹤0.01% 1943
2016
Q2 		$1.02M Sell
600
-193
-24% -$326K ﹤0.01% 1729
2016
Q1 		$1.39M Sell
793
-303
-28% -$482K 0.01% 1409
2015
Q4 		$1.93M Buy
1,096
+471
+75% +$834K 0.01% 1106
2015
Q3 		$1.07M Buy
625
+66
+12% +$159K 0.01% 1155
2015
Q2 		$1.51M Buy
559
+279
+100% +$725K 0.01% 1375
2015
Q1 		$809K Sell
280
-347
-55% -$962K ﹤0.01% 1704
2014
Q4 		$1.65M Buy
627
+544
+655% +$1.41M 0.01% 1112
2014
Q3 		$226K Buy
+83
New +$270K ﹤0.01% 1562

Other funds holding TRIB

HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
WN
Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.6B AUM 28.24% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

John Overdeck's TRIB Position: Q1 2026 in Review

John Overdeck sold out of Trinity Biotech (TRIB) in Q1 2026, closing a stake of 622 shares — an estimated $14.8K sold.

John Overdeck first reported a position in TRIB in Q3 2014 and held it in 27 quarters. The position peaked at $1.93M in Q4 2015. 21 funds tracked by Wall St. Rank hold TRIB as of Q1 2026.

  • John Overdeck reported no remaining Trinity Biotech position as of Q1 2026 after selling out during the quarter.
  • John Overdeck sold 622 Trinity Biotech shares in Q1 2026, an estimated $14.8K.
  • John Overdeck first reported a position in Trinity Biotech in Q3 2014 and held it in 27 quarters.
  • John Overdeck's Trinity Biotech position peaked at $1.93M in Q4 2015.
  • 21 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.